Literature DB >> 12684732

Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money.

Stacey C Sigmon1, Jennifer W Tidey, Gary J Badger, Stephen T Higgins.   

Abstract

RATIONALE: Psychomotor stimulants often increase cigarette smoking, although the mechanisms responsible for that effect remain unclear.
OBJECTIVE: The present study was conducted to extend our investigation of the effects of psychomotor stimulant use on the reinforcing effects of cigarette smoking.
METHODS: A progressive-ratio (PR) schedule was used to examine the acute effects of orally administered D-amphetamine (placebo, 5, 10, 15 mg/70 kg) on the reinforcing effects of smoking (2 puffs/ratio) and money (1.00 US dollar/ratio) in 18 adult smokers.
RESULTS: Among the overall sample of 18 smokers, D-amphetamine produced only a modest, non-significant increase in the amount of responding maintained by smoking (PR break point), but effects varied systematically between subjects. D-Amphetamine increased the smoking break point among ten subjects (responders), while leaving unchanged or decreasing the break point in the remaining eight individuals (non-responders). Responders also were more sensitive than non-responders to d-amphetamine's effects on visual-analog ratings of "high", "good effects", "drowsy", and "slurred speech", but not on other subject ratings (i.e., "bad effects", "jittery", "confused") or on any physiological measures (i.e., heart rate, blood pressure, skin temperature). D-Amphetamine did not significantly alter PR break point maintained by money.
CONCLUSIONS: These results provide further evidence that D-amphetamine can increase the reinforcing effects of cigarette smoking, at least among a subset of smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684732     DOI: 10.1007/s00213-003-1416-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Assessing individual differences in ethanol preference using a cumulative dosing procedure.

Authors:  H DeWit; J Pierri; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  A detailed analysis of the effects of d-amphetamine on behavior under fixed-interval schedules.

Authors:  M N Branch; L R Gollub
Journal:  J Exp Anal Behav       Date:  1974-05       Impact factor: 2.468

3.  Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure.

Authors:  M Kidorf; M L Stitzer; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1995-10       Impact factor: 4.492

4.  Enhancing caffeine reinforcement by behavioral requirements following drug ingestion.

Authors:  K Silverman; G K Mumford; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

5.  Effects of D-amphetamine on performance under a multiple schedule in the rat.

Authors:  F C Clark; B J Steele
Journal:  Psychopharmacologia       Date:  1966

6.  d-amphetamine increases choice of cigarette smoking over monetary reinforcement.

Authors:  J W Tidey; S C O'Neill; S T Higgins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

Review 7.  Sex differences in nicotine effects and self-administration: review of human and animal evidence.

Authors:  K A Perkins; E Donny; A R Caggiula
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

8.  Cigarette smoking and subjective response: effects of d-amphetamine.

Authors:  J E Henningfield; R R Griffiths
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

9.  Effects of d-amphetamine on choice of social versus monetary reinforcement: a discrete-trial test.

Authors:  S T Higgins; J R Hughes; W K Bickel
Journal:  Pharmacol Biochem Behav       Date:  1989-10       Impact factor: 3.533

10.  Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide.

Authors:  D Huston-Lyons; M Sarkar; C Kornetsky
Journal:  Pharmacol Biochem Behav       Date:  1993-10       Impact factor: 3.533

View more
  26 in total

1.  The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.

Authors:  Myung N Kim; Emily M Jutkiewicz; Minjia Zhang; Margaret E Gnegy
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

2.  Vulnerability to smokeless tobacco use among those dependent on alcohol or illicit drugs.

Authors:  Ryan Redner; Thomas J White; Valerie S Harder; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2013-09-30       Impact factor: 4.244

3.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

4.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

Review 5.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

6.  Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.

Authors:  Erin N Schoenfelder; Stephen V Faraone; Scott H Kollins
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

7.  Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

8.  Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.

Authors:  Emily M Jutkiewicz; Danielle M Nicolazzo; Myung N Kim; Margaret E Gnegy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

9.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

10.  Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder.

Authors:  Sean X Luo; Melanie Wall; Lirio Covey; Mei-Chen Hu; Jennifer M Scodes; Frances R Levin; Edward V Nunes; Theresa Winhusen
Journal:  Am J Drug Alcohol Abuse       Date:  2018-01-25       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.